Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis

Table 2 Effects of ASI on abnormal function of platelet in patients with UC (mean ± SD)

Group	n	PC(×109/L)	GMP-140 (ng/L)	TXB2 (ng/L)	6-keto-PGF1a (ng/L)	1 min PAR (%)	VWF:Ag (%)
Routine therapy
Before therapy	33	188.6 ± 38.5	52.3 ± 15.2	96.9 ± 38.1	13.9 ± 5.3	59.4 ± 14.7	149.1 ± 48.0
After therapy	31	179.3 ± 36.2c	48.8 ± 13.7c	87.7 ± 28.6c	16.2 ± 5.7c	53.1 ± 15.6c	137.3 ± 48.2c
ASI therapy
Before therapy	31	193.9 ± 41.4	51.1 ± 13.8	99.3 ± 33.1	12.7 ± 5.3	56.8 ± 17.2	139.5 ± 50.2
After therapy	30	171.3 ± 37.8a	37.0 ± 10.9b	70.2 ± 25.9b	16.4 ± 6.2c	45.3 ± 14.4b	102.4 ± 24.7b

^aP < 0.05,

^bP < 0.01,

^cP > 0.05 vs before therapy group.